Hemoadsorption in the critically ill-Final results of the International CytoSorb Registry
Standard
Hemoadsorption in the critically ill-Final results of the International CytoSorb Registry. / Hawchar, Fatime; Tomescu, Dana; Träger, Karl; Joskowiak, Dominik; Kogelmann, Klaus; Soukup, Jens; Friesecke, Singrun; Jacob, David; Gummert, Jan; Faltlhauser, Andreas; Aucella, Filippo; van Tellingen, Martijn; Malbrain, Manu L N G; Bogdanski, Ralph; Weiss, Günter; Herbrich, Andreas; Utzolino, Stefan; Nierhaus, Axel; Baumann, Andreas; Hartjes, Andreas; Henzler, Dietrich; Grigoryev, Evgeny; Fritz, Harald; Bach, Friedhelm; Schröder, Stefan; Weyland, Andreas; Gottschaldt, Udo; Menzel, Matthias; Zachariae, Olivier; Novak, Radovan; Berden, Jernej; Haake, Hendrik; Quintel, Michael; Kloesel, Stephan; Kortgen, Andreas; Stecher, Stephanie; Torti, Patricia; Nestler, Frieder; Nitsch, Markus; Olboeter, Detlef; Muck, Philip; Findeisen, Michael; Bitzinger, Diane; Kraßler, Jens; Benad, Martin; Schott, Martin; Schumacher, Ulrike; Molnar, Zsolt; Brunkhorst, Frank Martin.
in: PLOS ONE, Jahrgang 17, Nr. 10, e0274315, 2022.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hemoadsorption in the critically ill-Final results of the International CytoSorb Registry
AU - Hawchar, Fatime
AU - Tomescu, Dana
AU - Träger, Karl
AU - Joskowiak, Dominik
AU - Kogelmann, Klaus
AU - Soukup, Jens
AU - Friesecke, Singrun
AU - Jacob, David
AU - Gummert, Jan
AU - Faltlhauser, Andreas
AU - Aucella, Filippo
AU - van Tellingen, Martijn
AU - Malbrain, Manu L N G
AU - Bogdanski, Ralph
AU - Weiss, Günter
AU - Herbrich, Andreas
AU - Utzolino, Stefan
AU - Nierhaus, Axel
AU - Baumann, Andreas
AU - Hartjes, Andreas
AU - Henzler, Dietrich
AU - Grigoryev, Evgeny
AU - Fritz, Harald
AU - Bach, Friedhelm
AU - Schröder, Stefan
AU - Weyland, Andreas
AU - Gottschaldt, Udo
AU - Menzel, Matthias
AU - Zachariae, Olivier
AU - Novak, Radovan
AU - Berden, Jernej
AU - Haake, Hendrik
AU - Quintel, Michael
AU - Kloesel, Stephan
AU - Kortgen, Andreas
AU - Stecher, Stephanie
AU - Torti, Patricia
AU - Nestler, Frieder
AU - Nitsch, Markus
AU - Olboeter, Detlef
AU - Muck, Philip
AU - Findeisen, Michael
AU - Bitzinger, Diane
AU - Kraßler, Jens
AU - Benad, Martin
AU - Schott, Martin
AU - Schumacher, Ulrike
AU - Molnar, Zsolt
AU - Brunkhorst, Frank Martin
PY - 2022
Y1 - 2022
N2 - The aim of the current paper is to summarize the results of the International CytoSorb Registry. Data were collected on patients of the intensive care unit. The primary endpoint was actual in-hospital mortality compared to the mortality predicted by APACHE II score. The main secondary endpoints were SOFA scores, inflammatory biomarkers and overall evaluation of the general condition. 1434 patients were enrolled. Indications for hemoadsorption were sepsis/septic shock (N = 936); cardiac surgery perioperatively (N = 172); cardiac surgery postoperatively (N = 67) and "other" reasons (N = 259). APACHE-II-predicted mortality was 62.0±24.8%, whereas observed hospital mortality was 50.1%. Overall SOFA scores did not change but cardiovascular and pulmonary SOFA scores decreased by 0.4 [-0.5;-0.3] and -0.2 [-0.3;-0.2] points, respectively. Serum procalcitonin and C-reactive protein levels showed significant reduction: -15.4 [-19.6;-11.17] ng/mL; -17,52 [-70;44] mg/L, respectively. In the septic cohort PCT and IL-6 also showed significant reduction: -18.2 [-23.6;-12.8] ng/mL; -2.6 [-3.0;-2.2] pg/mL, respectively. Evaluation of the overall effect: minimal improvement (22%), much improvement (22%) and very much improvement (10%), no change observed (30%) and deterioration (4%). There was no significant difference in the primary outcome of mortality, but there were improvements in cardiovascular and pulmonary SOFA scores and a reduction in PCT, CRP and IL-6 levels. Trial registration: ClinicalTrials.gov Identifier: NCT02312024 (retrospectively registered).
AB - The aim of the current paper is to summarize the results of the International CytoSorb Registry. Data were collected on patients of the intensive care unit. The primary endpoint was actual in-hospital mortality compared to the mortality predicted by APACHE II score. The main secondary endpoints were SOFA scores, inflammatory biomarkers and overall evaluation of the general condition. 1434 patients were enrolled. Indications for hemoadsorption were sepsis/septic shock (N = 936); cardiac surgery perioperatively (N = 172); cardiac surgery postoperatively (N = 67) and "other" reasons (N = 259). APACHE-II-predicted mortality was 62.0±24.8%, whereas observed hospital mortality was 50.1%. Overall SOFA scores did not change but cardiovascular and pulmonary SOFA scores decreased by 0.4 [-0.5;-0.3] and -0.2 [-0.3;-0.2] points, respectively. Serum procalcitonin and C-reactive protein levels showed significant reduction: -15.4 [-19.6;-11.17] ng/mL; -17,52 [-70;44] mg/L, respectively. In the septic cohort PCT and IL-6 also showed significant reduction: -18.2 [-23.6;-12.8] ng/mL; -2.6 [-3.0;-2.2] pg/mL, respectively. Evaluation of the overall effect: minimal improvement (22%), much improvement (22%) and very much improvement (10%), no change observed (30%) and deterioration (4%). There was no significant difference in the primary outcome of mortality, but there were improvements in cardiovascular and pulmonary SOFA scores and a reduction in PCT, CRP and IL-6 levels. Trial registration: ClinicalTrials.gov Identifier: NCT02312024 (retrospectively registered).
KW - Humans
KW - Critical Illness/therapy
KW - Procalcitonin
KW - C-Reactive Protein
KW - Interleukin-6
KW - Sepsis/therapy
KW - ROC Curve
KW - Prognosis
KW - Shock, Septic
KW - Biomarkers
KW - Registries
U2 - 10.1371/journal.pone.0274315
DO - 10.1371/journal.pone.0274315
M3 - SCORING: Journal article
C2 - 36282800
VL - 17
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 10
M1 - e0274315
ER -
